1. Search Result

Search Result

Results for "137-58-6" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-B0185


    Sodium Channel MEK ERK NF-κB Cancer Cardiovascular Disease
    Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence. Lidocaine decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine is a commonly used local anesthetics of amide derivative, a drug to treat ventricular arrhythmia and an effective tumor-inhibitor.